INCB 39110-301 (GRAVITAS-301)

INCB 39110-301 (GRAVITAS-301)

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease (aGVHD) (GRAVITAS-301)


Study treatments


Inclusion criteria


Exclusion criteria


Participating sites

Link